Patricia Gallagher

Title: Patricia Gallagher: Innovator in Cancer Therapeutics

Introduction

Patricia Gallagher is a notable inventor based in Lewisville, NC (US). She has made significant contributions to the field of cancer therapeutics, holding a total of 3 patents that focus on innovative methods for treating cancer.

Latest Patents

Her latest patents include the development of Angiotensin (1-7) analogs and methods relating thereto. These analogs are designed to serve as therapeutic compositions for cancer treatment. Additionally, she has patented the use of angiotensin-(1-7) peptide as an anti-cancer therapeutic. This invention describes a composition that inhibits the growth of cancer cells by utilizing a pharmaceutically effective amount of an agonist for the angiotensin-(1-7) receptor. The application of these compounds is associated with increased expression of genes involved in tumor suppression and a decrease in the expression of known oncogenes.

Career Highlights

Throughout her career, Patricia has worked with esteemed institutions such as Wake Forest University and Tensive Controls, Inc. Her research has focused on the therapeutic potential of angiotensin-(1-7) in treating various cancers, including breast and lung cancer.

Collaborations

Patricia has collaborated with notable colleagues, including Carlos M. Ferrario and E. Ann Tallant, who have contributed to her research endeavors.

Conclusion

Patricia Gallagher's innovative work in cancer therapeutics highlights her commitment to advancing medical science. Her patents reflect a significant step forward in the fight against cancer, showcasing her role as a leading inventor in this critical field.